A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
Clinical trial NCT00257608 · COMPLETED
Trial details
- NCT number
- NCT00257608
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2014-11-01
- Enrollment
- 1145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.